These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8491227)
1. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. Wang SJ; Liu RS; Liu HC; Lin KN; Shan DE; Liao KK; Fuh JL; Lee LS Eur J Nucl Med; 1993 Apr; 20(4):339-44. PubMed ID: 8491227 [TBL] [Abstract][Full Text] [Related]
2. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279 [TBL] [Abstract][Full Text] [Related]
3. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. Liu RS; Lin KN; Wang SJ; Shan DE; Fuh JL; Yeh SH; Liu HC Nucl Med Commun; 1992 Oct; 13(10):744-8. PubMed ID: 1491839 [TBL] [Abstract][Full Text] [Related]
4. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472 [TBL] [Abstract][Full Text] [Related]
5. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography. Goulding P; Burjan A; Smith R; Lawson R; Snowden J; Northen B; Neary D; Testa H Eur J Nucl Med; 1990; 17(1-2):77-82. PubMed ID: 2083546 [TBL] [Abstract][Full Text] [Related]
6. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. Markus HS; Costa DC; Lees AJ J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):180-5. PubMed ID: 8126501 [TBL] [Abstract][Full Text] [Related]
7. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078 [TBL] [Abstract][Full Text] [Related]
8. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study. Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138 [TBL] [Abstract][Full Text] [Related]
9. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO). Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154 [TBL] [Abstract][Full Text] [Related]
10. [Inferior frontal region hypoperfusion in Parkinson disease with dementia]. Ochudło S; Opala G; Jasińska-Myga B; Siuda J; Nowak S Neurol Neurochir Pol; 2003; 37 Suppl 5():133-44. PubMed ID: 15098340 [TBL] [Abstract][Full Text] [Related]
11. Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study. Catafau AM; Lomeña FJ; Pavia J; Parellada E; Bernardo M; Setoain J; Tolosa E Eur J Nucl Med; 1996 Oct; 23(10):1329-37. PubMed ID: 8781137 [TBL] [Abstract][Full Text] [Related]